Jun D cooperates with p65 to activate the proximal κB site of the cyclin D1 promoter: Role of PI3K/PDK-1

Carcinogenesis

Volumn 29, Issue 3, 2008, Pages 536-543

  Toualbi Abed, Kahina ^a   Daniel, Fanny ^b   Güller, Meryem C ^a   Legrand, Agnès ^c   Mauriz, Jose Luis ^d   Mauviel, Alain ^a   Bernuau, Dominique ^a,e  

^a INSERM   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF LEÓN   (Spain)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D1; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P50; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REPORTER GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASE SEQUENCE; BINDING SITES; BLOOD; CHROMATIN IMMUNOPRECIPITATION; CHROMONES; CYCLIN D1; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; HUMANS; IMMUNOPRECIPITATION; MORPHOLINES; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR RELA;

EID: 40949099918     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm293     Document Type: Article

References (47)

1. Guttridge,D.C. et al. (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol., 19, 5785-5799.
2. Joyce,D. et al. (1999) Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem., 274, 25245-25249.
3. Karin,M. et al. (2002) NF-κB in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer, 2, 301-310.
4. Ibarra-Sanchez,M.J. et al. (2001) Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-kappaB activation. Oncogene, 20, 4728-4739.
5. Saitoh,M. et al. (2005) Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology, 146, 4917-4925.
6. Takebayashi,T. et al. (2003) NF-kappa B-dependent induction of cyclin D1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutant. J. Biol. Chem., 278, 14897-14905.
7. Fausto,N. et al. (1989) Regulation of liver growth: Protooncogenes and transforming growth factors. Lab. Invest., 60, 4-13.
8. Nadori,F. et al. (1997) Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation. Hepatology, 26, 1477-1483.
9. Albanese,C. et al. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem., 270, 23589-23597.
10. Brown,J.R. et al. (1998) Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell Biol., 18, 5609-5619.
11. Albanese,C. et al. (1999) Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J. Biol. Chem., 274, 34186-34195.
12. Wisdom,R. et al. (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J., 18, 188-197.
13. Stein,B. et al. (1993) Cross-coupling of the NF-kappa 8 p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J., 12, 3879-3891.
14. Yang,X. et al. (1999) ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. J. Biol. Chem., 274, 27981-27988.
15. Rahmani,M. et al. (2001) Functional cooperation between JunD and NF-kappaB in rat hepatocytes. Oncogene, 20, 5132-5142.
16. Toualbi,K. et al. (2007) Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes. Oncogene, 26, 3492-3502.
17. Peron,P. et al. (2001) Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. Role of phosphatidylinositol 3-kinase-induced AP-1 activation. J. Biol. Chem. 276, 10524-10531.
18. Wang,X. et al. (2005) Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/ Fra-2 AP-1 complexes. J. Virol., 79, 95-105.
19. Gille,H. et al. (1999) Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem., 274, 22033-22040.
20. Kane,L.P. et al. (1999) Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol., 9, 601-604.
21. Takuwa,N. et al. (1999) Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell Biol., 19, 1346-1358.
22. Rickheim,D.G. et al. (2002) Differential regulation of cyclins D1 and D3 in hepatocyte proliferation. Hepatology, 36, 30-38.
23. Nirula,A. et al. (2006) Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4. J. Exp. Med., 203, 1733-1744.
24. Perkins,N.D. et al. (1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science, 275, 523-527.
25. Gerritsen,M.E. et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl Acad. Sci. USA, 94, 2927-2932.
26. Zhong,H. et al. (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell, 1, 661-671.
27. Sheppard,K.A. et al. (1999) Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell Biol., 19 6367-6378.
28. Ashburner,B.P. et al. (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell Biol., 21, 7065-7077.
29. Zhong,H. et al. (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell, 9, 625-636.
30. Lee,S.K. et al. (2000) Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J. Biol. Chem., 275, 12470-12474.
31. Choi,Y.S. et al. (2005) PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. Mol. Cell, 20, 241-246.
32. Faniello,M.C. et al. (2002) An alternative model of H ferritin promoter transactivation by c-Jun. Biochem. J., 363, 53-58.
33. Su,M. et al. (2005) Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. J. Biol. Chem., 280, 38365-38375.
34. Verrecchia,F. et al. (2001) Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation. Oncogene 20, 2205-2211.
35. Lively,T.N. et al. (2001) C-Jun binds the N-terminus of humn TAF(II)250 to depress RNA polymerase II transcription in vitro. J. Biol. Chem., 276, 25582-25588.
36. Lively,T.N. et al. (2004) The basic leucine zipper domain of c-Jun functions in transcriptional activation through interaction with the N terminus of human TATA-binding protein-associated factor-1 (human TAF(II)250). J. Biol. Chem., 279, 26257-26265.
37. Herber,B. et al. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene, 9, 2105-2107.
38. Shaulian,E. et al. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol., 4, E131-E136.
39. Xie,P. et al. (2000) Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide kiinase and Akt. J. Biol. Chem., 275, 24907-24914.
40. Tanaka,H. et al. (2005) 3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling. J. Biol. Chem., 280, 40965-40973.
41. Mayo,M.W. et al. (2003) Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J. Biol. Chem., 278, 18980-18989.
42. Kim,Y.K. et al. (2006) Involvement of HDAC1 and the PI3K/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin. Biochem. Biophys. Res. Commun., 347, 1088-1093.
43. Moore,M.J. et al. (2002) Phosphorylation of the catalytic subunit of protein kinase A. Autophosphorylation versus phosphorylation by phosphoinositide-dependent kinase-1. J. Biol. Chem., 277, 47878-47884.
44. Guo,H. et al. (2007) Regulation of hepatitis B virus replication by phosphatidylinositol 3-kinase-AKT signal transduction pathway. J. Virol, 81, 10072-10080.
45. Boyault,S. et al. (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology, 45, 42-52.
46. Liu,P. et al. (2002) Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas. J. Hepatol., 37, 63-71.
47. Guo,L. et al. (2005) Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma. Life Sci., 77, 1869-1878.